Biotechnology Industry News

Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample This is concurrent with the fact that among the genomics, proteomics, metabolomics, and epigenetics techniques, genomics is the most widely used one. As the root cause of the cancer can be determined by studying which gene mutated and how, targeted therapies can be devised. Such analysis can also help ascertain if the patient would be at risk of a relapse. All these techniques and technologies find appl

One of the biggest factors propelling the demand for organ-on-chip is the increasing number of investments being made in research by the governments of several countries all around the world.   For instance, the National Center for Advancing Translational Sciences (NCATS) gave a research grant worth $2 million to Emulate Inc. in July 2017, in order to allow the company to leverage its human Brain-Chip system and create a fully automated research platform for conducting experiments on the International Space Station. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/organ-on-chip-market/report-sample The other major factor responsible for the rising demand for organ-on-chip is the increasing need for alternatives to the conventionally used animal models in research activities. In many countries, doctors and medical researchers are raising concerns over the scientific validity and translatability of the animal alternatives of human diseases and thi

Soaring number of initiatives by governments and private organizations for creating awareness amongst the people about the health and environmental benefits of alternative protein sources is one of the major factors responsible for the rise in the demand for protein extracts from single cell protein sources across the world. For instance, Valensa International, which is a major producer of microalgae-based nutraceuticals launched an alliance with a U.S. based trade organization called Algae Biomass Organization (ABO) in 2017 in order to create awareness amongst the masses about the consumption of microalgae as an alternative protein source.   Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/protein-extracts-from-single-cell-protein-sources-market/report-sample Due to the above-mentioned factors, the revenue generated from the worldwide sales of protein extracts from single protein sources will increase from $5.3 billion to $8.7 billion from 2017